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Abstract
Expanded carrier screening (ECS) aims to inform couples’ reproductive choice, preferably before conception. As part of an
implementation study in which trained general practitioners (GPs) offered a population-based ECS couple-test, we evaluated the
feasibility of the test-offer and degree of participant informed choice (IC). Trained GPs from nine practices in the northern
Netherlands invited 4295 female patients aged 18–40 to take part in couple-based ECS. Inclusion criteria were having a male
partner, planning for children and not being pregnant. We evaluated the feasibility of the organizational aspects, GP competence
and the content of the pre-test counselling. Participant satisfaction, evaluation of pre-test counselling and degree of IC were
measured using a longitudinal survey. We explored GP experiences and their views on future implementation through semi-
structured interviews. 130 consultations took place. All participating GPs were assessed by genetic professionals to be competent
to conduct pre-test counselling. Most (63/108 (58%)) consultations took place within the planned 20min (median 20, IQR 18–
28). GPs considered couples’ prior knowledge level an important determinant of consultation length. 91% of patients were (very)
satisﬁed with the GP counselling. After pre-test counselling, 231/237(97%) participants had sufﬁcient knowledge and 206/231
(88%) had a positive attitude and proceeded with testing. Our pilot demonstrates that offering couple-based ECS through trained
and motivated GPs is feasible. Future large-scale implementation requires a well-informed general public and a discussion about
appropriate reimbursement for GPs and health care coverage for couples. Providing (more) test information pre-appointment
may help reduce average consultation time.
Introduction
Next generation sequencing enables simultaneous screening
for carrier status of many genes associated with autosomal
recessive (AR) conditions and some X-linked conditions,
called expanded carrier screening (ECS) [1]. Where ECS is
done prior to pregnancy, couples found to be at increased risk
of having a child affected by such a condition can consider
alternative reproductive options such as in vitro fertilization
with pre-implantation genetic diagnosis (PGT-M) or prenatal
testing (PND) (with possible termination of an affected
pregnancy). However, a population-based ECS is not yet part
of regular pre-conception care in public health care systems,
but several private companies and some academic centers
have started to develop and offer ECS tests for individuals or
couples planning to conceive [2]. ECS aims to inform a
couple about their risk of conceiving children with these
genetic conditions. In this paper, describing the ﬁrst
population-based implementation pilot of an ECS test-offer
by GPs, we decided to focus on severe AR conditions.
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The Genetics Department of the University Medical
Centre Groningen (UMCG) in the Netherlands has devel-
oped and validated a couple-based ECS test for 50 AR
conditions associated with approximately 70 genes [3].
These conditions were selected because they are early onset,
serious diseases that result in severe physical or intellectual
disabilities, severe pain, or premature death. These criteria
were recommended by an international expert meeting at
the UMCG in 2013, are supported by literature [4–6] and
current guidelines which include criteria related to severity
of illness [1]. In the Dutch population approximately 1 in
150 couples are carriers for the same condition in this test
[7]. For severe AR conditions, the risk of being a carrier
couple for an AR condition is about 1% [8]. The percentage
of at risk couples that can be identiﬁed through ECS in the
general population depends on the composition of the test-
panel. For example, when 500 conditions (which are not all
serious) are included, detection rate is higher [9] than in our
(conservative) panel. Given that being a carrier of any AR
condition is common but the chance of carrying a particular
condition is very low, it is the positive combined ‘couple-
result’ which conveys clinical utility for reproduction. We
therefore argue that a responsible approach to implementing
ECS in a public health care system is to offer it as a couple
test and provide couple results only. This approach is sup-
ported by the recently published Belgian guidelines [10]. In
the test results, we report only causal recessive variants,
including known deleterious variants listed in databases
(e.g., Human Gene Mutation Database, Biobase, Qiagen),
and variants predicted to truncate or affect gene expression.
We have previously reported that both health care pro-
fessionals (HCPs) and the target population support couple-
based ECS in the general population with the GP as preferred
provider [3, 11], and other studies have demonstrated that
carrier testing for single-gene disorders such as cystic ﬁbrosis
(CF) and hemoglobinopathies in primary care is feasible and
acceptable [12, 13]. More than 99% of the Dutch population
are registered with a GP [14], and most GP care is included in
the mandatory health insurance package all Dutch citizens
carry. In the Dutch healthcare system, GPs play a central role
as gatekeeper for secondary or tertiary care [15], which makes
extending their current preconception care responsibilities to
include a population-based ECS offer a logical approach. We
therefore investigated whether test-provision by GPs could be
a feasible approach for ECS and result in informed choice of
couples who attended pre-test counselling. As most general
HCPs lack the skills, conﬁdence and knowledge to commu-
nicate clinical genetics issues [1, 16–18], we designed and
provided training to GPs and subsequently performed an
implementation study where these trained GPs offered the
UMCG ECS test to couples from the general population. This
current study is part of a larger study on the feasibility,
uptake, and psychological impact of the test-offer.
Methods
Provision of ECS test-offer and care
Fig. 1 displays the ECS test-offer and provision of care. By
sending out an invitation letter, participating GPs offered all
potentially eligible women registered in their practices the
opportunity to take part in the ECS testing program. Cou-
ples who were interested in the ECS test could make an
appointment for pre-test counselling with the inviting GP.
Afterwards they would decide whether or not to proceed
with testing. The ECS-test was only accessible to couples
who received pre-test counselling and couples were
required to attend pre-test counselling together.
Trained GPs were asked to provide pre-test counselling
about ECS in combination with general preconception care
(GPC) advice (e.g., advice about folic acid supplementation,
cessation of alcohol use or smoking). For this counselling, a
double-consultation time was available (20min). Referral to
the Clinical Genetics department of the UMCG was available
for couples identiﬁed to have prior increased risk, e.g., due to
suspected family history of a genetic condition. Couples who
proceeded with the ECS test could give a blood sample using
request forms provided by the GP. The UMCG Genomics
Laboratory performed the test. With a turn-around time of
8 weeks, GPs received a result for couples who provided
blood samples and then communicated the results to them. A
couple was considered a carrier couple if both couple mem-
bers have a class IV or V variant in one of the recessive
disease genes included in the test.
Carrier couples, but also non-carrier couples with
remaining questions, could be referred to Clinical Genetics
for post-test counselling. We also launched a publicly
accessible website with general information about the 50
AR conditions, the ECS test, and related procedures (www.
dragerschapstest.umcg.nl). The research team, including the
genetic counsellor involved, could be contacted through the
website. There were no patient expenditures associated with
the study and test-participation. PGT-M and PND for ser-
ious conditions such as those included in this ECS-test are
available to high risk couples. In the Netherlands, costs of
PGT-M and prenatal testing are covered by statutory health
insurance.
Study design
Figure 1 also depicts the study design. We used a mixed
methods longitudinal design with four study time points
(T0–T3), with couples and GPs as study participants. GPs
were asked to evaluate each individual pre-test counselling
at T1. At T3 they were invited to take part in semi-
structured one-to-one interviews to explore their overall
experience with test-provision. A genetics professional
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involved in the training supervised the ﬁrst two pre-test
counselling sessions of each GP. Couples were asked to ﬁll
out an online survey. Couples who attended pre-test coun-
selling received three (T0, T1, T3) to four (T0, T1, T2, T3)
questionnaires, depending on whether they proceeded with
testing. The study protocol was approved by the UMCG
Medical Research Ethics Committee (METc 2015/384).
Recruitment of GPs
Study participation was open to GPs in the catchment area
of the UMCG. Staff from the Genetics Department and the
Department of General Practice ﬁrst approached potentially
interested GPs personally and a recruitment message was
added to a newsletter for GPs. GPs from 34 practices
received the study information. Nineteen GPs from nine
practices agreed to participate. One practice (no. 9) with-
drew during the study because they were too busy to
facilitate study participation. No further invitations were
sent, but participants already included could still attend pre-
test counselling, and proceed with testing.
Prior to the start of the study, all GPs were required
to participate in a 2.5 h training session about pre-test
counselling developed by the research team. This training
session included background information about ECS
and other general aspects of preconception care and an
interactive session about reproductive genetic pre-test
counselling. An information booklet was provided
to complement the training that provided background
information and a counselling guideline with important
items to discuss. Two weeks after the training, all GPs
ﬁlled out an online questionnaire testing their knowledge.
GPs received individualized feedback on their incorrect
answers prior to start of the counselling. Support from the
clinical genetics professionals was available as needed
throughout the study.
Recruitment of couples
Between January and December 2016, participating GPs
selected and invited all potentially eligible women aged 18-40
registered in their practices to participate. Eligibility criteria
were not being pregnant, having a (male) partner and plan-
ning to have children with this partner. Pregnant women were
excluded, because the turnaround time of the test-result was a
maximum of eight weeks at that time. Additionally, the extra
skills probably needed for ‘urgency counselling regarding
ECS in pregnancy’ requires different counselling skills of GPs
which were not yet part of our preparatory training. The
women were asked to invite their partners in the study.
Couples who were interested in the ECS test could make an
appointment for pre-test counselling with the GP after both
partners had given written consent to participation. They
could decide whether to proceed with testing after attending
this appointment. Invitations were sent by mail and included a
letter signed by the GP, a response card and an information
leaﬂet. This test information leaﬂet consisted of the type of
conditions included in the test, the chances of being a carrier
couple and of having an affected child, reproductive options
available for carrier couples, and test procedures. It also
Fig. 1 Overview of ECS test-offer, provision of care and study design.
GPs provided pre-test counselling to couples interested in ECS testing.
Subsequently, couples could decide to proceed with testing. We used a
mixed-methods longitudinal study in which assessments were made at
four time points (T0-T3) through either questionnaires and/or semi-
structured interviews, with couples and participating GPs as study
participants
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included a link to the website for further information. Women
who were eligible and interested in participating received
more detailed study information.
Measures
Feasibility was evaluated in terms of the organizational
aspects of this GP-provided ECS test-offer and the provi-
sion of care, with a focus on the pre-test counselling. We
explored GP experiences and views on the ECS test to
evaluate feasibility and improve future implementation. We
adopted Marteau et al., (2001)’s deﬁnition of IC, who
developed the Multidimensional Measure of Informed
Choice (MMIC) to measure IC in relation to prenatal
screening for Down’s syndrome [19]. A choice was con-
sidered 'informed' if participants had sufﬁcient knowledge
and accepted the test offer (in case of a positive attitude) or
declined the test-offer (in case of a negative attitude) [19].
Table 1 displays the topics and items investigated, which
are based on relevant literature [1, 16, 17, 20–22]. The
organizational aspects of the ECS test-offer were evaluated
quantitatively as the time used for pre-test counselling and
qualitatively through analysis focused on barriers and
facilitators. Pre-test counselling was evaluated in terms of
competence, content and patient-satisfaction. Competence
was judged by the genetics professionals after supervision
and evaluated by GPs during the interviews. Both couples
and GPs evaluated the content. Couples also rated their
satisfaction with pre-test counselling. Speciﬁc measures,
instruments and details are described in Suppl. 1.
Quantitative data and analysis
Data on the duration of the consultation and items dis-
cussed during pre-test counselling were collected by a
checklist for GPs that was ﬁlled out after each pre-test
counselling (T1). The checklist included eleven items that
GPs were required to discuss during pre-test counselling
(see supplemental information for list). They were asked to
indicate if they discussed the item (yes, somewhat, no), and
if not, why not. Data on items discussed during pre-test
counselling (i.e., their perceived importance and time spent
on them), satisfaction with pre-test counselling and
informed choice were collected by couples’ questionnaires
using the Roqua online tool for conﬁdential clinical data
collection [23]. The IC measure consisted of ﬁve knowl-
edge items capturing essential information about ECS
testing and two attitude items. We also asked couples to ﬁll
out these knowledge items after pre-test counselling as part
of our provision of care to verify that couples who pro-
ceeded with testing were aware of the correct information.
We would call them for additional discussion if they
answered any of the ﬁve questions incorrectly. Couples
could refrain from having the test after this additional
information, which happened in one occasion. Data on
consultation duration, items discussed during counselling,
patient satisfaction, and informed choice were described
using percentages, mean (SD) or median (IQR) where
appropriate, using SPSS IBM version 23.
Qualitative data and analysis
Ten semi-structured one-to-one interviews were held with
GPs. Two GPs who conducted counselling did not parti-
cipate due to lack of time and the GP who withdrew from
the study did also not participate. A topic guide was
developed containing open-ended questions related to the
feasibility aspects of this GP-provided test. Interviews were
conducted by a trained researcher (JS), audio-recorded and
transcribed verbatim. The average duration of the inter-
views was 41 minutes (range 20-60 min). Data analysis was
conducted according to the framework approach of Ritchie
and Spencer [24]. Framework analysis follows a process of
familiarization, summarizing and coding, which results in
matrices presenting the data per theme and case to allow
more in depth analysis and comparison across interviewees.
Atlas –ti (version.5.2.18 copyright 1993-2018 by ATLAS.
ti Scientiﬁc Software Development GMbH Berlin) was
used to facilitate analysis. Two researchers (JS, LvdH)
independently coded the ﬁrst three interviews, and differ-
ences in coding were discussed until consensus was
reached. LvdH subsequently coded all interviews, includ-
ing the ﬁrst three, while JS coded parts of all interviews
randomly and where LvdH had doubts. Final thematic
framework matrices were subsequently discussed within
the research group until consensus was reached. The pre-
liminary conclusions were returned to the interviewees for




Table 2 shows that 19 GPs attended the training and 130
couples attended pre-test consultation of whom 117 pro-
ceeded with testing. Six trained GPs did not conduct pre-test
counselling for reasons unrelated to the study. A genetic
counsellor conducted one of the pre-test counselling ses-
sions because one couple found out they were already
pregnant after they had made their GP appointment. This
couple was excluded from the analysis. Ten GPs partici-
pated in the interviews. 240/260 (92%) of the individual
participants responded to the evaluation of the pre-test
counselling. GPs returned 116/129 (90%) checklists.
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Evaluation of organizational aspects
58% of the pre-test counselling sessions lasted 20minutes or
less, with a median (IQR) of 20 minutes (18–28), indicating
that the allocated time of 20minutes was sufﬁcient for the
majority of sessions. Qualitative ﬁndings from GP interviews
are illustrated with quotes presented in Table 3. Several GPs
noted that couples were well informed beforehand, and that
this helped them provide counselling within this time. GPs
expected pre-test counselling sessions to last longer, if cou-
ples were less well-informed, or for couples with little
educational background. Some GPs mentioned that over time
they developed a routine for conducting the counselling,
which reduced the time required for preparation and coun-
selling itself. GPs were positive about attendance of both
partners at counselling because the couple-test affects both
partners equally and because they considered discussing GPC
with both partners important. No carrier couples were iden-
tiﬁed. GPs did not experience any barriers in communicating
the normal results or to referring any couples at normal risk to
Clinical Genetics for additional pre- or post-test counselling.
GPs or their healthcare assistants communicated the test






1. Organizational aspects of GP-
provided ECS test offer
Checklist at T1 (GP) Start and end time of pre-test counselling
sessions
Barriers and facilitators of:
• Duration of pre-test counseling










• Self-judgment GPs during interviews
• Professional judgment genetics
professional after supervision
3. Evaluation of pre-test
counselling: content
Checklist at T1 (GP) Items discussed during counselling. Barriers and facilitators of: Discussing
the aspects included on the checklist
Survey at T1
(couples)
Importance and length of items discussed
during counselling.
4.Views about implementation Interview at T3 (GP) N.A.
B. Informed choice
Informed choice Survey at T0 and T1
(couples)
Informed choice measured using adapted
MMIC(2), see supplementary materials
Table 2 Overview of
participating GPs, pre-test






















1 (6) City 1 1 500 24 23
2 (4) City 1 1 528 12 12
3 (3) Village 2 1 276 4 3
4 (8&9) Town 6 4 1045 23 20
5 (2&5) Town 3 2 780 27 25
6 (1) Town 1 1 407 18 14
7 (7) Village 1 1 262 5 5
8 (10) Town 2 1 330 5 4
9 (NA) City 2 1 167 12 11
Total 19 13 4295 130 117
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results by phone, email, or a combination, and some provided
the couples with the lab results letter as well.
Evaluation of pre-test counseling
Based on their experiences in this study, GPs and genetics
professionals considered training test-providers essential to
ensuring quality of the test provision. After GPs were
supervised twice, the genetic professionals considered all
thirteen GPs competent to conduct counselling on their
own. Counselling support from the clinical genetics pro-
fessionals was requested twice for couples who were
pregnant during the study and once for a couple who had
misunderstood the purpose of the test. All GPs interviewed
said they felt able to provide the pre-test counselling mainly
because of the training, supervision and additionally pro-
vided materials. Some GPs speciﬁcally said they used the
study checklist as a practical guidance, and all felt this
covered the essential aspects of a pre-test counselling well.
Participants evaluated the pre-test counselling with a mean
satisfaction score of 4.7/5 (SD 0.5). The majority of parti-
cipants (54.7%) gave the highest score of 5.0. 91% of
participants were satisﬁed or very satisﬁed with GP pre-test
counselling.
GPs and couples evaluated the content of the pre-test
counselling as follows. GPs indicated that most aspects
included on the checklist, apart from GPC and ‘commu-
nication and turn-around time of the test-result’, were at
least discussed ‘somewhat’ in more than 90% of consulta-
tions. Some participants indicated that they thought too little
time was spent on discussing the conditions included in the
test (55 respondents (23%)) and the follow-up options for
high-risk couples (38 respondents (16%)). Some GPs
explained they did not discuss each condition in detail,
instead discussing the conditions as categories as explained
during the training. While GPs indicated that in 36 con-
sultations (31%) they either “did somewhat” or “did not”
discuss couples’ reproductive values, more than 85% of
participants indicated that the time spent on their and their
partners’ values was exactly right.
Most GPs were positive about combining ECS pre-test
counselling with GPC. GPs indicated that, for example, due
to lack of time, they “did not” discuss GPC in 31% or
discussed it “only somewhat” in 14% of consultations.
Some GPs explained during the interviews that the coun-
selling might become too complex preventing couples from
remembering both. GPC was considered important or very
important to discuss by 159 participants (67%), of whom
19/159 (12%) thought too little time was spent on this. In
contrast, 167 participants (70%) thought the right amount of
time was spent discussing GPC.
Informed choice
After pre-test counselling by the GP, the number of parti-
cipants with a sufﬁcient level of knowledge had improved
from 195/237 (83%) to 231/237 (97%) (Table 4). Five of
six participants who displayed insufﬁcient knowledge –and
a positive attitude- after pre-test counselling, proceeded
with testing. Another seven participants did not proceed
Table 3 GP quotes from interviews
Feasibility aspect Quote (Interviewee)
Evaluation of care: organizational aspects of the
GP-provided test-offer
“I particularly liked the training course, which was essential. It would be difﬁcult to
provide the ECS test without doing the training course ﬁrst.” Interviewee 10
“At ﬁrst, I thought 30 minutes should be planned for each consultation… But later I
reduced it to 20 minutes, because it was feasible in 20 minutes… Also because at a
certain moment you know what to discuss. Well, and people were often perfectly able to
tell about the test. Most of them.” Interviewee 5
Evaluation of care: content “I discussed the items on the checklist with everyone, because I thought those were the
essential points. So [amongst others] about what types of diseases were included. What
the chances were, that it [the ECS test] does not offer any guarantee [of a healthy baby],
and that there were no costs involved [for the couple]. That’s it, in brief.” Interviewee 5
“What is really important is that they realize that it’s the couple being tested and not the
individuals, that the result says nothing about each individual only something about the
couple together.” Interviewee 3
Views on future implementation: Suitable provider [reasons why the GP is suitable]…“well, of course it’s close to the patient, most patients,
even these healthy young people know their GP. And that means that, in a counselling
like this, the threshold to ask questions is likely to be lower, or to return. They know
where to ﬁnd us when they need to.” Interviewee 8
Views on future implementation “Well.., I think that with the right provision of information, it could very well be part of
this general preconception care advice.” Interviewee 4
Views on future implementation “The solidarity [healthcare insurance] system here [in the Netherlands] means that if you
want to reach people, you should cover the costs.” Interviewee 7
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with testing, even though their attitude was positive and
knowledge sufﬁcient. Our provision of care pathway –as
described in the methods section- prevented participants to
make a ﬁnal decision based on insufﬁcient knowledge.
GP views on future implementation
In line with our previous research, after having offered ECS
testing, GPs considered themselves as the most suitable pro-
viders for a population-based ECS couple-test. Advantages
they mentioned were the low-threshold of GP care, their
familiarity with their patients and their background. One GP
mentioned that ECS-provision as standard care by all GPs
might not be feasible because not all may be able to keep up
with technological advances in genetics. Some GPs suggested
that only motivated GPs willing to do so should be trained to
provide ECS. These GPs could become specialized in
(reproductive) genetics, just as some GPs are currently spe-
cialized in areas such as palliative or elderly care. Potential
barriers that GPs mentioned were resistance to additional
workload in already too busy practices or negative attitudes
towards ECS. The eight-week turnaround time in our study,
was considered acceptable by the GPs for non-pregnant
couples. For future implementation, several GPs suggested
the laboratory could also send the test result directly to cou-
ples. Negotiations with health insurance companies and pol-
icy makers were considered necessary to decide on a proper
reimbursement fee for test-provision and whether to include
ECS in the statutory health insurance package (Table 3).
Discussion
In this paper we have presented the design of our imple-
mentation study of a GP-provided ECS couple-test and our
results on its feasibility and the degree of informed choice in
couples attending pre-test counselling. Implementing ECS
responsibly requires a novel approach [1], and our previous
research suggested an important role for GPs [3, 11]. Our
study demonstrates that implementing an ECS couple-test
consisting of a limited set of severe conditions in the GP
setting is a feasible approach that results in an informed
decision in most cases.
Importantly, all participating GPs felt and were judged
competent to conduct pre-test counselling after being given
training, supported by genetic professionals on demand, and
assisted by a counselling-checklist. Participating couples were
very satisﬁed with GP pre-test counselling and the Dutch
Society of General Practitioners recently stated their support
for (more) studies investigating the implementation of ECS in
primary care [26]. This approach therefore has the potential to
address the concerns about the current lack of genetic literacy
and counselling skills among non-genetics HCPs providing
genetic tests [1, 18–20], and our results can inform options for
responsible mainstreaming in genetics.
Most pre-test counselling sessions were conducted
within the allotted time span of 20 minutes, with additional
counselling sometimes needed to discuss GPC. In some
situations, it might be more effective to separate the two
types of counseling: directive (e.g., advice not to smoke or
drink alcohol) and non-directive (facilitate reproductive
decision-making in line with couples’ values).
A study of CF carrier testing in primary care showed that
GPs could conduct the (less complex) counselling in an
average of 12 minutes [12]. According to participating GPs,
pre-test counselling within the allocated time was facilitated
because couples were already well-informed, perhaps due to
the extensive study information, website and the ques-
tionnaires participants ﬁlled out.
Our results suggest that GPs could have extended their
pre-test discussion of the reproductive options available for
couples who are found to be both carriers of the same
condition, which would also include an assessment of the
value system held by that couple. Such discussions are
standard practice for GPs, but our future training could be
adjusted to focus more on these aspects in the preconception
setting. Couples do not often request preconception con-
sultations from GPs or other HCPs in the Netherlands [27],
thus an added beneﬁt of the ECS test-offer meant that GPs
could discuss or follow-up on GPC advice with more
couples –and both partners- than was routine. Future
research could also explore whether prenatal carrier
screening is feasible in this setting and what necessary
adjustments should ﬁrst be made in training and test-
delivery. In the study we required both partners to attend
pre-test counselling together and GPs agreed that it was
preferable to include both partners jointly in the discussion
of ECS as this affects both prospective parents. To lower
practical barriers to attend counselling, in the future GPs
could use web-consultations or face-to-face consultations at
times desired (evenings/weekends), although this requires
additional training and adjusted infrastructure.
Considerations regarding large-scale
implementation of ECS in primary care
Our research concentrated on the offer of ECS within pri-
mary care. Eligible women were actively and individually
approached by their GP by letter. Large scale implementa-
tion could also be a more passive and collective approach,
e.g., via posters, leaﬂets and information about the test on
GPs’ websites. However, this requires the public to become
more knowledgeable on this topic, which means more
educational efforts would need to be aimed at this group.
Moreover, couples could ﬁll out an online decision-aid in
advance to inform and prepare them and facilitate efﬁcient
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and effective pre-test counseling. No major barriers to large-
scale implementation were mentioned by GPs in our study
provided they can use 20 minutes for the counselling and
that there are no ﬁnancial barriers for them and their
patients. Our results should inform discussions with rele-
vant stakeholders to negotiate reimbursement for the con-
sultation as well as the test.
GPs in our study suggested that ECS could be provided
by ‘specialized’ GPs who focus on a speciﬁc aspect of GP
care. Not all GPs may be interested in investing the time and
effort necessary to obtain and maintain the required coun-
selling skills, considering that the total number of coun-
selling sessions per GP might be relatively low. The
specialization approach would guarantee the necessary
minimum number of pre-test counselling sessions per GP
per year to maintain competence. GP specialization already
exists in the Netherlands in areas such as elderly and pal-
liative care. Other primary HCPs involved in preconception
care—such as midwives, community pediatricians or nurse
practitioners—might also be willing to offer ECS. In all
scenarios, the role of Clinical Genetics in a population-
based ECS couple-test could focus on education, support/
auditing and post-test counselling for carrier couples.
A couple-based test for severe recessive conditions
only
Salient features of our approach to ECS were the well-
considered composition of the test-panel and the provision
of couple-only results for this population-based offer
through participating GPs. The composition of the panel
facilitated a generic type of consent and the couple-based
strategy resulted in a minimal need for post-test counselling
by the GP or Clinical Genetics professionals. As time to
discuss all conditions in detail is limited and some couples
desire more information, extensive information about the
conditions should be easily accessible for couples, as was
the case on our website. Not disclosing individual results
remains a matter of debate given the perceived utility for
cascade screening [22], as well as the participants’ personal
preferences [28].
We argue that previous cascade screening approaches
disclosing individual results, e.g., for relatively frequent
conditions, are no longer helpful when switching to
population-based ECS, especially given that everyone is
likely to be a carrier of one or more recessive conditions. If
ECS was well known to the public and to HCPs and there
were no (ﬁnancial) barriers to participating, the new approach
would be to offer ECS testing to all couples wishing to
reproduce. Whilst some have expressed concern that indivi-
dual results are important if couples split up, our response to
this is that a new couple test, i.e., a re-analysis of the couple’s
or one of the couple’s stored data, could be done in those
cases. In the Dutch health care system these data (and the
DNA) are stored for these and other purposes. A referral to
Clinical Genetics would only be necessary for couples with
prior/suspected increased risk due to family and/or personal
health history and/or ethnic background. The approach sug-
gested in this study applies for ECS aimed at AR diseases
only. Our couple-based approach for severe AR conditions
could (and perhaps should) be complemented with individual
screening for more prevalent X-linked conditions like Fragile-
X and Duchenne muscular dystrophy. It is important to
evaluate in future studies what would be necessary aditionally
to facilitate counselling and test-provision and which adjust-
ment would be needed for responsible implementation in the
Dutch public health system. In this paper we focused on free
couple-based ECS in the Dutch public health system. We
anticipate that for non-reimbursed ECS and ECS in a private
setting, arguments for couple-based ECS or reporting of
individual carrier results could well be different. A discussion
of these arguments is beyond the scope of this paper.
Conclusions and recommendations
This GP-provided couple-based ECS test for a limited
number of severe AR conditions in the setting of pre-
conception care, presents a timely and responsible option to
inform couples planning a pregnancy about their chances of
having a child affected by a severe genetic condition. This
approach was not only feasible in our setting, but also led to
an informed choice for most participants. Future national
Table 4 informed choice before and after pre-test counselling by the GP
Before pre-test counselling (T0) (n= 237) Positive attitude n (%) Negative attitude n (%) Neutral attitude n (%) Total n (%)
Sufﬁcient knowledge 173 (83) 0 (0) 22 (79) 195 (83.)
Insufﬁcient knowledge 36 (17) 0 (0) 6 (21) 42 (18)
Total 209 (88) 0 28 (12) 237
After pre-test counselling (T1) (n= 237) Positive attitude n (%) Negative attitude n (%) Neutral attitude n (%) Total n (%)
Sufﬁcient knowledge 213 (90) 0 (0) 18 (8) 231 (97)
Insufﬁcient knowledge 5 (2) 0 (0) 1 (0) 6 (2.5)
Total 218 (92) 0 (0) 19 (8) 237
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implementation could involve other dedicated GPs, or other
primary HCPs willing to be trained to provide the test,
given that support as well as practical tools from a clinical
genetics service are available. Furthermore, some factors
identiﬁed in our study should be considered, such as raising
public awareness to facilitate a well-informed population
and resolution of reimbursement issues. Our approach, that
was feasible in the (northern) Netherlands, might be trans-
ferable to other (European) public health systems with
easily accessible primary health providers who are willing
to be trained and have the necessary resources to offer ECS.
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